Inventor · disambiguated record
Séverine Bezie
Also filed as: BEZIE SEVERINE · BEZIE SÉVERINE
5 granted patents·4 pending applications·2 citations·filing 2016–2021
66Inventor score
Top patents by PatentIndex Score
9 records- 0180US11090362B2Pharmaceutical composition comprising IL-34 and a mTOR inhibitorINST NAT SANTE RECH MED·Filed 2018·Granted Aug 17, 2021·2 cites·4 claims
- 0273US12083163B2Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseasesINST NAT SANTE RECH MED·Filed 2021·Granted Sep 10, 2024·0 cites·11 claims
- 0363US12146159B2Methods for obtaining regulatory t cells and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Nov 19, 2024·0 cites·12 claims
- 0456US10724001B2Methods for obtaining regulatory T cells and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Jul 28, 2020·0 cites·12 claims
- 0548US2022064260A1Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregsINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0646US10591465B2Methods and kits for labeling, detection and isolation of Foxp3+ regulatory T cells, isolated population of Foxp3+ regulatory T cells thus obtained and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Mar 17, 2020·0 cites·17 claims
- 0745US2021147801A1Methods for increasing expansion and immunosuppressive capacity of a population of cd8+cd45rclow/- tregsINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 0838US2020319164A1Methods for detecting, assessing severity and treating multiple sclerosisINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
- 0932US2018251731A1Subpopulation of cd8+cd45rclow tregs and uses thereofINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Séverine Bezie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →